166 related articles for article (PubMed ID: 22812495)
1. Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis.
Prislovsky A; Zeng X; Sokolic RA; Garabedian EN; Anur P; Candotti F; Strom TS
Platelets; 2013; 24(4):288-96. PubMed ID: 22812495
[TBL] [Abstract][Full Text] [Related]
2. Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.
Prislovsky A; Marathe B; Hosni A; Bolen AL; Nimmerjahn F; Jackson CW; Weiman D; Strom TS
Exp Hematol; 2008 May; 36(5):609-23. PubMed ID: 18346836
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption.
Marathe BM; Prislovsky A; Astrakhan A; Rawlings DJ; Wan JY; Strom TS
Exp Hematol; 2009 Nov; 37(11):1353-63. PubMed ID: 19733207
[TBL] [Abstract][Full Text] [Related]
4. Increased uptake by splenic red pulp macrophages contributes to rapid platelet turnover in WASP(-) mice.
Prislovsky A; Strom TS
Exp Hematol; 2013 Sep; 41(9):789-98. PubMed ID: 23727585
[TBL] [Abstract][Full Text] [Related]
5. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
6. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets.
Oda A; Ochs HD; Druker BJ; Ozaki K; Watanabe C; Handa M; Miyakawa Y; Ikeda Y
Blood; 1998 Sep; 92(6):1852-8. PubMed ID: 9731041
[TBL] [Abstract][Full Text] [Related]
7. WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling.
Shcherbina A; Cooley J; Lutskiy MI; Benarafa C; Gilbert GE; Remold-O'Donnell E
Br J Haematol; 2010 Feb; 148(3):416-27. PubMed ID: 19863535
[TBL] [Abstract][Full Text] [Related]
8. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich syndrome protein and platelets.
Oda A; Ochs HD
Immunol Rev; 2000 Dec; 178():111-7. PubMed ID: 11213795
[TBL] [Abstract][Full Text] [Related]
10. WASP and N-WASP in human platelets differ in sensitivity to protease calpain.
Shcherbina A; Miki H; Kenney DM; Rosen FS; Takenawa T; Remold-O'Donnell E
Blood; 2001 Nov; 98(10):2988-91. PubMed ID: 11698281
[TBL] [Abstract][Full Text] [Related]
11. The thrombocytopenia of WAS: a familial form of ITP?
Strom TS
Immunol Res; 2009; 44(1-3):42-53. PubMed ID: 18854955
[TBL] [Abstract][Full Text] [Related]
12. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
Shcherbina A; Rosen FS; Remold-O'Donnell E
J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
[TBL] [Abstract][Full Text] [Related]
14. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
15. Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.
Falet H; Marchetti MP; Hoffmeister KM; Massaad MJ; Geha RS; Hartwig JH
Blood; 2009 Nov; 114(21):4729-37. PubMed ID: 19692704
[TBL] [Abstract][Full Text] [Related]
16. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis.
Lorenzi R; Brickell PM; Katz DR; Kinnon C; Thrasher AJ
Blood; 2000 May; 95(9):2943-6. PubMed ID: 10779443
[TBL] [Abstract][Full Text] [Related]
17. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
18. Genotype-proteotype linkage in the Wiskott-Aldrich syndrome.
Lutskiy MI; Rosen FS; Remold-O'Donnell E
J Immunol; 2005 Jul; 175(2):1329-36. PubMed ID: 16002738
[TBL] [Abstract][Full Text] [Related]
19. Normal Arp2/3 complex activation in platelets lacking WASp.
Falet H; Hoffmeister KM; Neujahr R; Hartwig JH
Blood; 2002 Sep; 100(6):2113-22. PubMed ID: 12200375
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
